nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0845	0.3	CbGbCtD
Amitriptyline—ALB—Furosemide—dilated cardiomyopathy	0.0747	0.265	CbGbCtD
Amitriptyline—ABCB1—Lisinopril—dilated cardiomyopathy	0.065	0.231	CbGbCtD
Amitriptyline—ABCB1—Spironolactone—dilated cardiomyopathy	0.0572	0.203	CbGbCtD
Amitriptyline—KCND3—endocardium—dilated cardiomyopathy	0.0571	0.338	CbGeAlD
Amitriptyline—CYP2C9—cardial valve—dilated cardiomyopathy	0.0171	0.101	CbGeAlD
Amitriptyline—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.0104	0.0476	CcSEcCtD
Amitriptyline—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00924	0.0547	CbGeAlD
Amitriptyline—HTR7—pulmonary artery—dilated cardiomyopathy	0.00916	0.0542	CbGeAlD
Amitriptyline—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.00891	0.0528	CbGeAlD
Amitriptyline—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00889	0.0408	CcSEcCtD
Amitriptyline—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00571	0.0338	CbGeAlD
Amitriptyline—Indecainide—SCN5A—dilated cardiomyopathy	0.0056	0.402	CrCbGaD
Amitriptyline—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00555	0.0329	CbGeAlD
Amitriptyline—KCND2—cardiac ventricle—dilated cardiomyopathy	0.00551	0.0327	CbGeAlD
Amitriptyline—NTRK2—heart—dilated cardiomyopathy	0.00548	0.0325	CbGeAlD
Amitriptyline—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00534	0.0245	CcSEcCtD
Amitriptyline—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00516	0.0237	CcSEcCtD
Amitriptyline—KCND3—cardiac ventricle—dilated cardiomyopathy	0.0048	0.0285	CbGeAlD
Amitriptyline—KCND3—myocardium—dilated cardiomyopathy	0.00452	0.0268	CbGeAlD
Amitriptyline—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0042	0.0193	CcSEcCtD
Amitriptyline—KCNQ3—heart—dilated cardiomyopathy	0.00415	0.0246	CbGeAlD
Amitriptyline—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00405	0.0186	CcSEcCtD
Amitriptyline—Ataxia—Spironolactone—dilated cardiomyopathy	0.00394	0.0181	CcSEcCtD
Amitriptyline—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00362	0.0166	CcSEcCtD
Amitriptyline—KCND2—heart—dilated cardiomyopathy	0.00362	0.0214	CbGeAlD
Amitriptyline—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00358	0.0164	CcSEcCtD
Amitriptyline—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00349	0.016	CcSEcCtD
Amitriptyline—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00333	0.0153	CcSEcCtD
Amitriptyline—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00323	0.0148	CcSEcCtD
Amitriptyline—KCND3—heart—dilated cardiomyopathy	0.00315	0.0187	CbGeAlD
Amitriptyline—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00307	0.0141	CcSEcCtD
Amitriptyline—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00301	0.0138	CcSEcCtD
Amitriptyline—Aprindine—SCN5A—dilated cardiomyopathy	0.00291	0.209	CrCbGaD
Amitriptyline—Mental disability—Furosemide—dilated cardiomyopathy	0.00272	0.0125	CcSEcCtD
Amitriptyline—KCND3—cardiac atrium—dilated cardiomyopathy	0.0027	0.016	CbGeAlD
Amitriptyline—Alopecia—Spironolactone—dilated cardiomyopathy	0.00256	0.0117	CcSEcCtD
Amitriptyline—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00255	0.0117	CcSEcCtD
Amitriptyline—HRH2—heart—dilated cardiomyopathy	0.00246	0.0146	CbGeAlD
Amitriptyline—Purpura—Furosemide—dilated cardiomyopathy	0.00236	0.0108	CcSEcCtD
Amitriptyline—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00235	0.0108	CcSEcCtD
Amitriptyline—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00234	0.0107	CcSEcCtD
Amitriptyline—Malaise—Spironolactone—dilated cardiomyopathy	0.00227	0.0104	CcSEcCtD
Amitriptyline—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00226	0.162	CrCbGaD
Amitriptyline—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00226	0.0104	CcSEcCtD
Amitriptyline—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.00223	0.0132	CbGeAlD
Amitriptyline—Irritability—Furosemide—dilated cardiomyopathy	0.00217	0.00998	CcSEcCtD
Amitriptyline—Urinary retention—Furosemide—dilated cardiomyopathy	0.00217	0.00994	CcSEcCtD
Amitriptyline—Discomfort—Spironolactone—dilated cardiomyopathy	0.00212	0.00973	CcSEcCtD
Amitriptyline—HRH2—cardiac atrium—dilated cardiomyopathy	0.0021	0.0125	CbGeAlD
Amitriptyline—SIGMAR1—myocardium—dilated cardiomyopathy	0.0021	0.0124	CbGeAlD
Amitriptyline—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00208	0.00955	CcSEcCtD
Amitriptyline—Confusional state—Spironolactone—dilated cardiomyopathy	0.00208	0.00952	CcSEcCtD
Amitriptyline—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00201	0.00925	CcSEcCtD
Amitriptyline—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00197	0.00906	CcSEcCtD
Amitriptyline—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00195	0.00895	CcSEcCtD
Amitriptyline—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.0019	0.00873	CcSEcCtD
Amitriptyline—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00184	0.00846	CcSEcCtD
Amitriptyline—Somnolence—Spironolactone—dilated cardiomyopathy	0.00183	0.0084	CcSEcCtD
Amitriptyline—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00182	0.00835	CcSEcCtD
Amitriptyline—Arthritis—Lisinopril—dilated cardiomyopathy	0.00176	0.00807	CcSEcCtD
Amitriptyline—Drowsiness—Furosemide—dilated cardiomyopathy	0.00176	0.00806	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00174	0.00801	CcSEcCtD
Amitriptyline—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00171	0.00784	CcSEcCtD
Amitriptyline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0017	0.00778	CcSEcCtD
Amitriptyline—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.0017	0.00778	CcSEcCtD
Amitriptyline—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00164	0.00752	CcSEcCtD
Amitriptyline—Urticaria—Spironolactone—dilated cardiomyopathy	0.00163	0.0075	CcSEcCtD
Amitriptyline—Irritability—Lisinopril—dilated cardiomyopathy	0.00163	0.00749	CcSEcCtD
Amitriptyline—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00163	0.00747	CcSEcCtD
Amitriptyline—CHRM2—heart—dilated cardiomyopathy	0.00161	0.00955	CbGeAlD
Amitriptyline—Ataxia—Lisinopril—dilated cardiomyopathy	0.00161	0.00738	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00156	0.00716	CcSEcCtD
Amitriptyline—ALB—heart—dilated cardiomyopathy	0.00152	0.00898	CbGeAlD
Amitriptyline—Tinnitus—Furosemide—dilated cardiomyopathy	0.00147	0.00674	CcSEcCtD
Amitriptyline—SIGMAR1—heart—dilated cardiomyopathy	0.00146	0.00867	CbGeAlD
Amitriptyline—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00146	0.00671	CcSEcCtD
Amitriptyline—Pruritus—Spironolactone—dilated cardiomyopathy	0.00146	0.00668	CcSEcCtD
Amitriptyline—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00144	0.0066	CcSEcCtD
Amitriptyline—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00141	0.00646	CcSEcCtD
Amitriptyline—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00141	0.00646	CcSEcCtD
Amitriptyline—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0014	0.00644	CcSEcCtD
Amitriptyline—Dizziness—Spironolactone—dilated cardiomyopathy	0.00136	0.00625	CcSEcCtD
Amitriptyline—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00136	0.00624	CcSEcCtD
Amitriptyline—Weight increased—Lisinopril—dilated cardiomyopathy	0.00134	0.00617	CcSEcCtD
Amitriptyline—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00134	0.00617	CcSEcCtD
Amitriptyline—Vomiting—Spironolactone—dilated cardiomyopathy	0.00131	0.00601	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.0013	0.00596	CcSEcCtD
Amitriptyline—Rash—Spironolactone—dilated cardiomyopathy	0.0013	0.00596	CcSEcCtD
Amitriptyline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0013	0.00595	CcSEcCtD
Amitriptyline—Vision blurred—Furosemide—dilated cardiomyopathy	0.00129	0.00593	CcSEcCtD
Amitriptyline—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00129	0.00593	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00129	0.00593	CcSEcCtD
Amitriptyline—Headache—Spironolactone—dilated cardiomyopathy	0.00129	0.00592	CcSEcCtD
Amitriptyline—Jaundice—Lisinopril—dilated cardiomyopathy	0.00128	0.00589	CcSEcCtD
Amitriptyline—Agitation—Furosemide—dilated cardiomyopathy	0.00126	0.00579	CcSEcCtD
Amitriptyline—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.00125	0.00741	CbGeAlD
Amitriptyline—HTR7—heart—dilated cardiomyopathy	0.00125	0.00741	CbGeAlD
Amitriptyline—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00123	0.00564	CcSEcCtD
Amitriptyline—Leukopenia—Furosemide—dilated cardiomyopathy	0.00123	0.00564	CcSEcCtD
Amitriptyline—Nausea—Spironolactone—dilated cardiomyopathy	0.00122	0.00561	CcSEcCtD
Amitriptyline—ADRA1A—heart—dilated cardiomyopathy	0.00121	0.00714	CbGeAlD
Amitriptyline—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00118	0.00543	CcSEcCtD
Amitriptyline—Hallucination—Lisinopril—dilated cardiomyopathy	0.00118	0.0054	CcSEcCtD
Amitriptyline—Dry mouth—Furosemide—dilated cardiomyopathy	0.00114	0.00524	CcSEcCtD
Amitriptyline—Confusional state—Furosemide—dilated cardiomyopathy	0.00113	0.00518	CcSEcCtD
Amitriptyline—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00111	0.0797	CrCbGaD
Amitriptyline—Tinnitus—Lisinopril—dilated cardiomyopathy	0.0011	0.00506	CcSEcCtD
Amitriptyline—Shock—Furosemide—dilated cardiomyopathy	0.0011	0.00506	CcSEcCtD
Amitriptyline—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0011	0.00503	CcSEcCtD
Amitriptyline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00108	0.00497	CcSEcCtD
Amitriptyline—Anorexia—Furosemide—dilated cardiomyopathy	0.00107	0.0049	CcSEcCtD
Amitriptyline—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00106	0.00485	CcSEcCtD
Amitriptyline—Hypotension—Furosemide—dilated cardiomyopathy	0.00105	0.0048	CcSEcCtD
Amitriptyline—Alopecia—Lisinopril—dilated cardiomyopathy	0.00104	0.0048	CcSEcCtD
Amitriptyline—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00101	0.00463	CcSEcCtD
Amitriptyline—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00101	0.00461	CcSEcCtD
Amitriptyline—Somnolence—Furosemide—dilated cardiomyopathy	0.000995	0.00457	CcSEcCtD
Amitriptyline—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000973	0.00447	CcSEcCtD
Amitriptyline—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00097	0.00445	CcSEcCtD
Amitriptyline—Fatigue—Furosemide—dilated cardiomyopathy	0.000965	0.00443	CcSEcCtD
Amitriptyline—Tremor—Lisinopril—dilated cardiomyopathy	0.000964	0.00443	CcSEcCtD
Amitriptyline—Constipation—Furosemide—dilated cardiomyopathy	0.000957	0.00439	CcSEcCtD
Amitriptyline—CYP2B6—heart—dilated cardiomyopathy	0.000956	0.00566	CbGeAlD
Amitriptyline—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000955	0.00438	CcSEcCtD
Amitriptyline—CYP2C9—heart—dilated cardiomyopathy	0.000946	0.00561	CbGeAlD
Amitriptyline—Malaise—Lisinopril—dilated cardiomyopathy	0.000928	0.00426	CcSEcCtD
Amitriptyline—Syncope—Lisinopril—dilated cardiomyopathy	0.000923	0.00424	CcSEcCtD
Amitriptyline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000923	0.00423	CcSEcCtD
Amitriptyline—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000921	0.00423	CcSEcCtD
Amitriptyline—ADRA2A—heart—dilated cardiomyopathy	0.000917	0.00543	CbGeAlD
Amitriptyline—Palpitations—Lisinopril—dilated cardiomyopathy	0.00091	0.00417	CcSEcCtD
Amitriptyline—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000905	0.00415	CcSEcCtD
Amitriptyline—Urticaria—Furosemide—dilated cardiomyopathy	0.000889	0.00408	CcSEcCtD
Amitriptyline—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000885	0.00406	CcSEcCtD
Amitriptyline—Anxiety—Lisinopril—dilated cardiomyopathy	0.000873	0.00401	CcSEcCtD
Amitriptyline—Discomfort—Lisinopril—dilated cardiomyopathy	0.000866	0.00397	CcSEcCtD
Amitriptyline—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000857	0.00393	CcSEcCtD
Amitriptyline—Confusional state—Lisinopril—dilated cardiomyopathy	0.000847	0.00389	CcSEcCtD
Amitriptyline—Oedema—Lisinopril—dilated cardiomyopathy	0.00084	0.00386	CcSEcCtD
Amitriptyline—Shock—Lisinopril—dilated cardiomyopathy	0.000827	0.00379	CcSEcCtD
Amitriptyline—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000823	0.00378	CcSEcCtD
Amitriptyline—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00082	0.00376	CcSEcCtD
Amitriptyline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000812	0.00373	CcSEcCtD
Amitriptyline—Asthenia—Furosemide—dilated cardiomyopathy	0.000803	0.00369	CcSEcCtD
Amitriptyline—Anorexia—Lisinopril—dilated cardiomyopathy	0.000801	0.00368	CcSEcCtD
Amitriptyline—Pruritus—Furosemide—dilated cardiomyopathy	0.000792	0.00364	CcSEcCtD
Amitriptyline—Hypotension—Lisinopril—dilated cardiomyopathy	0.000785	0.0036	CcSEcCtD
Amitriptyline—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000784	0.00465	CbGeAlD
Amitriptyline—HTR2A—heart—dilated cardiomyopathy	0.00078	0.00462	CbGeAlD
Amitriptyline—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000766	0.00352	CcSEcCtD
Amitriptyline—Insomnia—Lisinopril—dilated cardiomyopathy	0.00076	0.00349	CcSEcCtD
Amitriptyline—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000754	0.00346	CcSEcCtD
Amitriptyline—Somnolence—Lisinopril—dilated cardiomyopathy	0.000747	0.00343	CcSEcCtD
Amitriptyline—Dizziness—Furosemide—dilated cardiomyopathy	0.00074	0.0034	CcSEcCtD
Amitriptyline—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000739	0.00339	CcSEcCtD
Amitriptyline—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00073	0.00335	CcSEcCtD
Amitriptyline—Fatigue—Lisinopril—dilated cardiomyopathy	0.000724	0.00332	CcSEcCtD
Amitriptyline—Constipation—Lisinopril—dilated cardiomyopathy	0.000718	0.0033	CcSEcCtD
Amitriptyline—Vomiting—Furosemide—dilated cardiomyopathy	0.000712	0.00327	CcSEcCtD
Amitriptyline—Rash—Furosemide—dilated cardiomyopathy	0.000706	0.00324	CcSEcCtD
Amitriptyline—Dermatitis—Furosemide—dilated cardiomyopathy	0.000705	0.00324	CcSEcCtD
Amitriptyline—Headache—Furosemide—dilated cardiomyopathy	0.000701	0.00322	CcSEcCtD
Amitriptyline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000692	0.00318	CcSEcCtD
Amitriptyline—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.000676	0.0485	CrCbGaD
Amitriptyline—Urticaria—Lisinopril—dilated cardiomyopathy	0.000667	0.00306	CcSEcCtD
Amitriptyline—Nausea—Furosemide—dilated cardiomyopathy	0.000665	0.00305	CcSEcCtD
Amitriptyline—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000664	0.00305	CcSEcCtD
Amitriptyline—Asthenia—Lisinopril—dilated cardiomyopathy	0.000603	0.00277	CcSEcCtD
Amitriptyline—Desipramine—SLC22A5—dilated cardiomyopathy	0.000602	0.0432	CrCbGaD
Amitriptyline—Pruritus—Lisinopril—dilated cardiomyopathy	0.000594	0.00273	CcSEcCtD
Amitriptyline—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000575	0.00264	CcSEcCtD
Amitriptyline—Dizziness—Lisinopril—dilated cardiomyopathy	0.000556	0.00255	CcSEcCtD
Amitriptyline—Vomiting—Lisinopril—dilated cardiomyopathy	0.000534	0.00245	CcSEcCtD
Amitriptyline—Rash—Lisinopril—dilated cardiomyopathy	0.00053	0.00243	CcSEcCtD
Amitriptyline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000529	0.00243	CcSEcCtD
Amitriptyline—Headache—Lisinopril—dilated cardiomyopathy	0.000526	0.00242	CcSEcCtD
Amitriptyline—ABCB1—heart—dilated cardiomyopathy	0.000511	0.00303	CbGeAlD
Amitriptyline—Nausea—Lisinopril—dilated cardiomyopathy	0.000499	0.00229	CcSEcCtD
Amitriptyline—Desipramine—ADRB1—dilated cardiomyopathy	0.000416	0.0299	CrCbGaD
Amitriptyline—Desipramine—ADRB2—dilated cardiomyopathy	0.00035	0.0251	CrCbGaD
Amitriptyline—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.35e-05	7.4e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.34e-05	7.38e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.34e-05	7.37e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.34e-05	7.35e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.33e-05	7.34e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.32e-05	7.31e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.31e-05	7.28e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.31e-05	7.26e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.31e-05	7.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.3e-05	7.24e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.29e-05	7.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.29e-05	7.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.28e-05	7.17e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.27e-05	7.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.27e-05	7.15e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.27e-05	7.13e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.26e-05	7.1e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.25e-05	7.08e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.25e-05	7.08e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.25e-05	7.07e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.24e-05	7.06e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.24e-05	7.05e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.24e-05	7.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.24e-05	7.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.24e-05	7.04e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	2.23e-05	7.02e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.21e-05	6.96e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.21e-05	6.96e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.21e-05	6.96e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.21e-05	6.95e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.21e-05	6.95e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.21e-05	6.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.21e-05	6.94e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.2e-05	6.93e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.19e-05	6.9e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.19e-05	6.88e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.19e-05	6.87e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	2.18e-05	6.85e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.18e-05	6.85e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.18e-05	6.85e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	2.17e-05	6.84e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.17e-05	6.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.17e-05	6.82e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	2.16e-05	6.8e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.14e-05	6.75e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.12e-05	6.66e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	2.11e-05	6.64e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.1e-05	6.61e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.1e-05	6.59e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.08e-05	6.56e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	2.08e-05	6.54e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.08e-05	6.54e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	2.08e-05	6.54e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.08e-05	6.53e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.08e-05	6.53e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.08e-05	6.53e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.07e-05	6.5e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.07e-05	6.5e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	2.06e-05	6.49e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	2.05e-05	6.46e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.05e-05	6.45e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.05e-05	6.44e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.05e-05	6.44e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.05e-05	6.44e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.02e-05	6.36e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.01e-05	6.34e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.99e-05	6.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.98e-05	6.22e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	1.97e-05	6.19e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	1.96e-05	6.17e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.96e-05	6.15e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.94e-05	6.1e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.92e-05	6.04e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.89e-05	5.95e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.89e-05	5.93e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.88e-05	5.92e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.88e-05	5.92e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	1.88e-05	5.91e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.87e-05	5.9e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.87e-05	5.87e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.86e-05	5.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.85e-05	5.82e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.85e-05	5.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.85e-05	5.82e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.82e-05	5.73e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.81e-05	5.69e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.8e-05	5.66e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	1.8e-05	5.66e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.79e-05	5.64e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.79e-05	5.64e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.79e-05	5.63e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.78e-05	5.61e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.78e-05	5.61e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.78e-05	5.61e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.78e-05	5.59e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.77e-05	5.58e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.77e-05	5.56e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.77e-05	5.56e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.76e-05	5.54e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.76e-05	5.52e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—CD36—dilated cardiomyopathy	1.75e-05	5.51e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.72e-05	5.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.72e-05	5.41e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.7e-05	5.35e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.7e-05	5.34e-05	CbGpPWpGaD
Amitriptyline—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	5.32e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.68e-05	5.27e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.67e-05	5.27e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.67e-05	5.26e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.66e-05	5.24e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.66e-05	5.23e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.65e-05	5.19e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.63e-05	5.13e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.63e-05	5.12e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.61e-05	5.07e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.61e-05	5.06e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.6e-05	5.04e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.59e-05	5e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.58e-05	4.97e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AGT—dilated cardiomyopathy	1.58e-05	4.96e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.57e-05	4.93e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.56e-05	4.92e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.56e-05	4.91e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.55e-05	4.89e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.55e-05	4.87e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.55e-05	4.87e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.54e-05	4.85e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.54e-05	4.84e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.54e-05	4.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.53e-05	4.83e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.53e-05	4.83e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.53e-05	4.82e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.53e-05	4.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.53e-05	4.81e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.53e-05	4.81e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.52e-05	4.77e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1.52e-05	4.77e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.51e-05	4.76e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.51e-05	4.76e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.51e-05	4.76e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.51e-05	4.75e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.51e-05	4.74e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.48e-05	4.67e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	1.48e-05	4.64e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.47e-05	4.63e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.47e-05	4.61e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.46e-05	4.61e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1.45e-05	4.55e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	1.44e-05	4.54e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	1.44e-05	4.54e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.44e-05	4.52e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.43e-05	4.51e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.42e-05	4.48e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.42e-05	4.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.42e-05	4.47e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.42e-05	4.45e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.4e-05	4.41e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.4e-05	4.41e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.39e-05	4.38e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.39e-05	4.37e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.38e-05	4.36e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.38e-05	4.34e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.37e-05	4.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.36e-05	4.29e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	1.36e-05	4.28e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.36e-05	4.27e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.35e-05	4.25e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.33e-05	4.19e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.33e-05	4.18e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	1.33e-05	4.18e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.33e-05	4.17e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.32e-05	4.16e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.32e-05	4.15e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.31e-05	4.12e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.31e-05	4.11e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.3e-05	4.1e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	4.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.3e-05	4.1e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.29e-05	4.06e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.28e-05	4.01e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	3.99e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.27e-05	3.99e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.24e-05	3.9e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.24e-05	3.89e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.23e-05	3.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.23e-05	3.86e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.23e-05	3.86e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.21e-05	3.81e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.18e-05	3.72e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.17e-05	3.68e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.15e-05	3.61e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.15e-05	3.6e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	3.59e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	3.59e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.14e-05	3.58e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	3.5e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.09e-05	3.43e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.08e-05	3.38e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.07e-05	3.37e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.07e-05	3.36e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.07e-05	3.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	3.35e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.07e-05	3.35e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.06e-05	3.34e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.06e-05	3.34e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.05e-05	3.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.05e-05	3.3e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.05e-05	3.3e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	3.27e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.03e-05	3.23e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.02e-05	3.2e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1e-05	3.16e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1e-05	3.15e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	9.9e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	9.89e-06	3.11e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	9.83e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.75e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	9.62e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	9.43e-06	2.97e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	9.38e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	9.35e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	9.34e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.23e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.21e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.18e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	9.15e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	9.11e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	9.07e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.04e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	8.94e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	8.87e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.49e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	8.41e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	8.41e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.4e-06	2.64e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	7.99e-06	2.51e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.33e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	7.29e-06	2.29e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	7.03e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.98e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.85e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.43e-06	2.02e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.33e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.32e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.3e-06	1.98e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	6.28e-06	1.97e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.22e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.2e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	6.17e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.76e-06	1.81e-05	CbGpPWpGaD
